FILE - In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. (Photo illustration by Anna Moneymaker/Getty Images) NEW ORLEANS - Legal arguments over women's access to a drug used in the most common method of abortion move to a federal appeals court in New Orleans on Wednesday, in a case challenging a Food and Drug Administration decision made more than two decades ago.The closely watched case is likely to wind up at the Supreme Court, which already has intervened to keep the drug, mifepristone, available while the legal fight winds through the courts.The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
The justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone.Three 5th U.S.
Circuit Court of Appeals judges with a history of supporting abortion restrictions are set to hear arguments. At issue are the FDA's initial approval of mifepristone in 2000, and FDA actions making the drug more accessible in later years.
The judges won't rule immediately.Judges nominated to the district court and appeals court by former President Donald Trump are playing major roles in the case, which is being argued almost a year after the Supreme Court overturned the Roe v.